(Press-News.org) Philadelphia, PA, August 8, 2011 – Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies. The results of this study have been published today in the September issue of The American Journal of Pathology.
"The central role of capillary sprouting in tumor vascularization makes it an attractive target for anticancer therapy. Our observations suggest, however, that targeting just this mode of blood vessel formation may not be sufficient to result in a significant antitumor effect," commented lead investigators Sándor Paku, PhD, Semmelweis University, Budapest, and Balazs Dome, MD, PhD, Medical University of Vienna.
Investigators from the Semmelweis University, the National Institute of Oncology, and the National Koranyi Institute of Pulmonology, Budapest, Hungary, and the Medical University of Vienna, Vienna, Austria, used electron and confocal microscopy to examine tumor tissue in mice in which malignant tumor cells had been introduced. They proposed a novel mechanism for the development of tissue pillars (the most characteristic feature of intussusceptive angiogenesis, in which a vessel folds into itself to form two vessels). Moreover, they demonstrated a significant increase in pillar formation after treatment with the angiogenesis inhibitor vatalanib. Their observations support the notion that inhibition of just a single tumor vascularization mechanism can trigger alternative ones.
Prior to this study, the mechanism of pillar formation had not been fully understood. Investigation revealed a progression of events that generates a connection between the processes of endothelial bridging and intussusceptive angiogenesis resulting in rapid pillar formation from pre-existing building blocks. To describe this mechanism of pillar formation the group coined the term "inverse sprouting."
"It is well established now that tumors can obtain sufficient blood supply from alternative vascularization mechanisms (such as intussusceptive angiogenesis) to grow without capillary sprouting (known as the key mode of new vessel formation in cancer). Therefore, antiangiogenic therapies should be tailored depending on the angiogenic phenotype in each single tumor, and the targeting of non-sprouting angiogenic mechanisms in cancer seems to be a rational strategy. Our study provides new understanding of cancer-induced intussusceptive angiogenesis and may serve as a basis for the development of novel drugs targeting this type of blood vessel formation."
###
The article is "A New Mechanism for Pillar Formation during Tumor-Induced Intussusceptive Angiogenesis," by Sándor Paku, Katalin Dezsö, Edina Bugyik, József Tóvári, József Tímár, Péter Nagy, Viktoria Laszlo, Walter Klepetko, and Balázs Döme (doi: 10.1016/j.ajpath.2011.05.033). It will appear in The American Journal of Pathology, Volume 179, Issue 3 (September 2011) published by Elsevier.
Researchers gain new insights into how tumor cells are fed
Shows promise for development of anti-tumor drugs
2011-08-09
ELSE PRESS RELEASES FROM THIS DATE:
Genetic analysis of amniotic fluid shows promise for monitoring fetal development
2011-08-09
Philadelphia, PA, August 8, 2011 – Researchers have demonstrated the feasibility of focused fetal gene expression analysis of target genes found in amniotic fluid using Standardized NanoArray PCR (SNAP) technology. This analysis could be used to monitor fetal development, enabling clinicians to determine very early in pregnancy whether fetal organ systems are developing normally. The study appears today in the September issue of The Journal of Molecular Diagnostics.
Using a previously developed SNAP gene panel as proof of concept, investigators from the Floating Hospital ...
Early morning smokers have increased risk of lung and head and neck cancers
2011-08-09
Two new studies have found that smokers who tend to take their first cigarette soon after they wake up in the morning may have a higher risk of developing lung and head and neck cancers than smokers who refrain from lighting up right away. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the results may help identify smokers who have an especially high risk of developing cancer and would benefit from targeted smoking interventions to reduce their risk.
Cigarette smoking increases one's likelihood of developing various types of ...
Technique to stimulate heart cells may lead to light-controlled pacemakers
2011-08-09
A new technique that stimulates heart muscle cells with low-energy light raises the possibility of a future light-controlled pacemaker, researchers reported in Circulation: Arrhythmia & Electrophysiology, a journal of the American Heart Association.
"Electronic cardiac pacemakers and defibrillators are well established and successful technologies, but they are not without problems, including the breakage of metal leads, limited battery life and interference from strong magnetic fields," said Emilia Entcheva, Ph.D., senior author of the study and associate professor of ...
Siblings of those with blood clots in leg have higher risk of same disorder
2011-08-09
Siblings of those who have been hospitalized with potentially lethal blood clots in the legs or pelvis are more likely to also suffer the disorder than those with healthy siblings, according to research published in Circulation: Journal of the American Heart Association.
The Swedish study is the first to show a direct correlation between venous thromboembolism (VTE) and family risk in a nationwide setting, sorted by age and gender.
VTE consists of deep vein thrombosis (DVT), which typically involves blood clots that form in the deep veins of the leg or pelvis, and ...
Light speed hurdle to invisibility cloak overcome by undergraduate
2011-08-09
An undergraduate student has overcome a major hurdle in the development of invisibility cloaks by adding an optical device into their design that not only remains invisible itself, but also has the ability to slow down light.
The optical device, known as an 'invisible sphere', would slow down all of the light that approaches a potential cloak, meaning that the light rays would not need to be accelerated around the cloaked objects at great speeds ― a requirement that has limited invisibility cloaks to work only in a specified region of the visible spectrum.
This ...
Drug development in the blink of an eye
2011-08-09
The development of drugs for brain-related conditions is not an efficient process; only 8% of candidate drugs that enter clinical trials gain FDA approval. A key reason for this low success rate is a lack of preclinical tests that accurately predict drug efficacy and detect unwanted side effects. But now, Jeremy Nathans and colleagues, at Johns Hopkins University School of Medicine, Baltimore, have developed a new preclinical approach that they hope can be used alongside current strategies to guide more efficient drug development for brain-related conditions.
In the study, ...
JCI online early table of contents: August 8, 2011
2011-08-09
EDITOR'S PICK: Drug development in the blink of an eye
The development of drugs for brain-related conditions is not an efficient process; only 8% of candidate drugs that enter clinical trials gain FDA approval. A key reason for this low success rate is a lack of preclinical tests that accurately predict drug efficacy and detect unwanted side effects. But now, Jeremy Nathans and colleagues, at Johns Hopkins University School of Medicine, Baltimore, have developed a new preclinical approach that they hope can be used alongside current strategies to guide more efficient ...
When and how to toilet train children
2011-08-09
Parents often ask their doctors for advice on toilet training young children, and a new article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/site/embargo/cmaj110830.pdf summarizes current approaches and evidence to help physicians respond to these queries.
"Toilet training is felt to be a natural process that occurs with development, yet very little scientific information is available for physicians who care for children," writes Dr. Darcie Kiddoo, Divisions of Pediatric Surgery and Urology, University of Alberta, Edmonton, ...
Gladstone scientist discovers genetic factor implicated in heartbeat defect
2011-08-09
SAN FRANCISCO, CA—August 8, 2011—A scientist at the Gladstone Institutes has discovered how gene regulation can make hearts beat out of sync, offering new hope for the millions who suffer from a potentially fatal heart condition.
In a paper being published this week in the online Early Edition of the Proceedings of the National Academy of Sciences, Gladstone Investigator Benoit G. Bruneau, PhD announces the identity of the molecular regulator that uses electrical impulses to synchronize each heartbeat.
Abnormalities in heartbeat synchronization, called heart arrhythmias, ...
Study urges caution with lenalidomide dosage
2011-08-09
COLUMBUS, Ohio – An early phase multiple myeloma trial has unexpectedly revealed that the drug lenalidomide interacts with another protein in cells that affect its dose level in the body, say researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) who conducted the study.
Lenalidomide is an anti-inflammatory drug, and more than 390 clinical trials have been initiated to study its activity in a number of cancers and other diseases.
The study found that lenalidomide ...
LAST 30 PRESS RELEASES:
Massage Therapy Foundation awards $300,000 research grant to the University of Denver
Gastrointestinal toxicity linked to targeted cancer therapies in the United States
Countdown to the Bial Award in Biomedicine 2025
Blood marker from dementia research could help track aging across the animal world
Birds change altitude to survive epic journeys across deserts and seas
Here's why you need a backup for the map on your phone
ACS Central Science | Researchers from Insilico Medicine and Lilly publish foundational vision for fully autonomous “Prompt-to-Drug” pharmaceutical R&D
Increasing the number of coronary interventions in patients with acute myocardial infarction does not appear to reduce death rates
Tackling uplift resistance in tall infrastructures sustainably
Novel wireless origami-inspired smart cushioning device for safer logistics
Hidden genetic mismatch, which triples the risk of a life-threatening immune attack after cord blood transplantation
Physical function is a crucial predictor of survival after heart failure
Striking genomic architecture discovered in embryonic reproductive cells before they start developing into sperm and eggs
Screening improves early detection of colorectal cancer
New data on spontaneous coronary artery dissection (SCAD) – a common cause of heart attacks in younger women
How root growth is stimulated by nitrate: Researchers decipher signalling chain
Scientists reveal our best- and worst-case scenarios for a warming Antarctica
Cleaner fish show intelligence typical of mammals
AABNet and partners launch landmark guide on the conservation of African livestock genetic resources and sustainable breeding strategies
Produce hydrogen and oxygen simultaneously from a single atom! Achieve carbon neutrality with an 'All-in-one' single-atom water electrolysis catalyst
Sleep loss linked to higher atrial fibrillation risk in working-age adults
Visible light-driven deracemization of α-aryl ketones synergistically catalyzed by thiophenols and chiral phosphoric acid
Most AI bots lack basic safety disclosures, study finds
How competitive gaming on discord fosters social connections
CU Anschutz School of Medicine receives best ranking in NIH funding in 20 years
Mayo Clinic opens patient information office in Cayman Islands
Phonon lasers unlock ultrabroadband acoustic frequency combs
Babies with an increased likelihood of autism may struggle to settle into deep, restorative sleep, according to a new study from the University of East Anglia.
National Reactor Innovation Center opens Molten Salt Thermophysical Examination Capability at INL
International Progressive MS Alliance awards €6.9 million to three studies researching therapies to address common symptoms of progressive MS
[Press-News.org] Researchers gain new insights into how tumor cells are fedShows promise for development of anti-tumor drugs